retaine MGD description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

retaine MGD

OCuSOFT, INC.
OCuSOFT, INC.

Drug Facts


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active Ingredients

Light Mineral Oil (0.5)................................Emollient

Mineral Oil (0.5%).....................................Emollient

retaine MGD Uses

For use as a protectant against further irritation or to relieve dryness of the eye.

Warnings

For use in the eyes only.

Do not use

  • if this product changes color.

When using this product

  • do not touch tip of container to any surface to avoid contamination.
  • do not reuse once opened.

Stop use and ask a doctor if

  • you feel eye pain or changes in vision, continued redness or irritation of the eye.
  • the condition worsens or persists for more than 72 hours.

KEEP OUT OF THE REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

  • Shake well before using.
  • Instill 1 or 2 drops in the affected eye(s) as needed and discard container.

Other Information

  • Use only if printed tamper seals on top and bottom flaps are intact.
  • Drops appear as a milky white solution.
  • Store between 15o-30oC (59o-86oF).

Inactive ingredients

Cetalkonium chloride, glycerol, poloxamer 188, tris hydrochloride, tromethamine, tyloxapol, water for injection.

Questions?

Call (800)233-5469 M-F 8:30AM-5:00PM CST or visit www.retainebrand.com

Purpose

Emollient

retaine MGD

retaine MGD

Mineral Oil EMULSION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:54799-917
Route of Administration OPHTHALMIC DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
LIGHT MINERAL OIL .002 mL
Mineral Oil .002 mL

Inactive Ingredients

Ingredient Name Strength
CETALKONIUM CHLORIDE
GLYCERIN
POLOXAMER 188
TROMETHAMINE HYDROCHLORIDE
tromethamine
TYLOXAPOL
water

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 0.4 in 1 VIAL, SINGLE-DOSE
2 NDC:54799-917-30 30 in 1 CONTAINER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part349 2012-01-05


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.